Article info

Download PDFPDF
Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment
  1. Correspondence to Dr Paolo Alboni, Division of Cardiology, Ospedale Civile, Cento (FE) 44042, Italy; p.alboni{at}ausl.fe.it
View Full Text

Citation

Alboni P, Botto GL, Boriani G, et al
Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment

Publication history

  • Accepted November 30, 2009
  • First published March 29, 2010.
Online issue publication 
March 29, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.